Vicarious Surgical (RBOTW) Gains from Investment Securities (2021 - 2025)
Vicarious Surgical (RBOTW) reported Gains from Investment Securities of $738483.0 for Q3 2025, up 102.49% year-over-year from $364704.0 in Q3 2024, and up 70.16% quarter-over-quarter from $433983.0 in Q2 2025.
Vicarious Surgical (RBOTW) Gains from Investment Securities (2021 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 5 years of Gains from Investment Securities data on file, last reported at $738483.0 in Q3 2025.
- Gains from Investment Securities for Q3 2025 came in at $738483.0, up 102.49% year-over-year; the trailing twelve-month figure through Sep 2025 was $738483.0 (up 102.49% YoY), and the FY2024 annual result was $709939.0, up 405.01% from the prior year.
- Gains from Investment Securities climbed to $738483.0 in Q3 2025 per RBOTW's latest filing, from $433983.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $19.6 million in Q2 2021 and troughed at -$17.6 million in Q2 2022.
- A 5-year average of -$3093.2 and a median of $123510.0 in 2024 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2025: Gains from Investment Securities tumbled 9275100.0% in 2022, then soared 933.33% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $4.0 in 2021, then plunged by 9275100.0% to -$371000.0 in 2022, then plunged by 1770.35% to -$6.9 million in 2023, then surged by 90.56% to -$655000.0 in 2024, then surged by 212.75% to $738483.0 in 2025.
- Business Quant data shows RBOTW's Gains from Investment Securities at $738483.0 in Q3 2025, $433983.0 in Q2 2025, and $93000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Vicarious Surgical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 738,483.00 |
| Sep 30, 2025 | 738,483.00 |
| Jun 30, 2025 | 433,983.00 |
| Jun 30, 2025 | 433,983.00 |
| Mar 31, 2025 | 93,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | -655,000.00 |
| Dec 31, 2024 | -655,000.00 |
| Sep 30, 2024 | 364,704.00 |
| Sep 30, 2024 | 364,704.00 |
| Jun 30, 2024 | 123,510.00 |
| Jun 30, 2024 | 123,510.00 |
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | -6.94 Mn |
| Dec 31, 2023 | -6.94 Mn |
| Sep 30, 2023 | 140,577.00 |
| Sep 30, 2023 | 140,577.00 |
| Jun 30, 2023 | -5.08 Mn |
| Jun 30, 2023 | -5.08 Mn |